Published in J Korean Med Sci on August 01, 2008
Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients. J Assist Reprod Genet (2009) 1.07
The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles. J Assist Reprod Genet (2012) 0.97
Serum anti-Müllerian hormone as a predictive marker of polycystic ovarian syndrome. Int J Gen Med (2011) 0.92
Comparing serum basal and follicular fluid levels of anti-Müllerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome. Ann Saudi Med (2010) 0.86
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod (2004) 3.57
Antimüllerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril (2002) 3.03
Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod (2003) 2.30
Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology (2002) 2.25
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome. Fertil Steril (1997) 2.13
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril (2002) 2.10
Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 2.06
Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta (2006) 1.89
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril (2004) 1.81
Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG (2005) 1.71
Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol (2004) 1.61
High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod (2005) 1.60
Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod (2004) 1.48
Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod (2005) 1.41
Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod (2003) 1.32
State of the art in in-vitro oocyte maturation. Curr Opin Obstet Gynecol (2004) 1.25
Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online (2006) 1.16
Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod (2005) 1.09
Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome. Hum Reprod (2000) 1.06
Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril (2005) 0.98
Oocyte maturity and preimplantation development in relation to follicle diameter in gonadotropin-releasing hormone agonist or antagonist treatments. Fertil Steril (2006) 0.93
Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization. J Assist Reprod Genet (2003) 0.88
Use of serum inhibin B levels at the start of ovarian stimulation and at oocyte pickup in the prediction of assisted reproduction treatment outcome. Fertil Steril (2005) 0.85
Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders. Hum Reprod (2002) 0.84
Inhibins and activins in human ovulation, conception and pregnancy. Hum Reprod Update (1998) 0.80
A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol (2012) 2.43
[Efficacy of initial treatment with peginterferon alpha-2a versus peginterferon alpha-2b in combination with ribavirin in naive chronic hepatitis C patients living in Daejeon and Chungcheong Province in Korea: a comparative study]. Korean J Hepatol (2008) 1.50
[Docetaxel-cisplatin-5-FU combination chemotherapy as a first-line treatment in patients with metastatic or recurred gastric cancer]. Korean J Gastroenterol (2007) 1.41
Analysis of the transforming growth factor beta1 gene -509 C/T polymorphism in patients with advanced-stage endometriosis. Fertil Steril (2009) 1.39
Derivation and characterization of new human embryonic stem cell lines: SNUhES1, SNUhES2, and SNUhES3. Stem Cells (2005) 1.37
Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Müllerian hormone levels. Fertil Steril (2009) 1.31
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod (2008) 1.26
Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 1.21
Cellular manipulation of human embryonic stem cells by TAT-PDX1 protein transduction. Mol Ther (2005) 1.14
Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage. Exp Mol Med (2010) 1.14
Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet (2006) 1.08
Methods for expansion of human embryonic stem cells. Stem Cells (2005) 1.07
Use of letrozole versus clomiphene citrate combined with gonadotropins in intrauterine insemination cycles: a pilot study. Fertil Steril (2006) 1.07
Hysteroscopic resection of the vaginal septum in uterus didelphys with obstructed hemivagina: a case report. J Korean Med Sci (2007) 1.07
Formylchromone derivatives as a novel class of protein tyrosine phosphatase 1B inhibitors. Bioorg Med Chem Lett (2003) 1.06
Impact of blastocyst transfer on offspring sex ratio and the monozygotic twinning rate: a systematic review and meta-analysis. Fertil Steril (2008) 1.03
Ectopic pregnancy after assisted reproductive technology: what are the risk factors? Curr Opin Obstet Gynecol (2010) 1.02
Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. Fertil Steril (2008) 1.01
Alterations of proliferative and differentiation potentials of human embryonic stem cells during long-term culture. Exp Mol Med (2008) 1.00
Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clin Obstet Gynecol (2010) 0.98
Analysis of serum levels of anti-Mullerian hormone, inhibin B, insulin-like growth factor-I, insulin-like growth factor binding protein-3, and follicle-stimulating hormone with respect to age and menopausal status. J Korean Med Sci (2008) 0.97
Implementation Issues of Virtual Desktop Infrastructure and Its Case Study for a Physician's Round at Seoul National University Bundang Hospital. Healthc Inform Res (2012) 0.97
MicroRNAs transfected into granulosa cells may regulate oocyte meiotic competence during in vitro maturation of mouse follicles. Hum Reprod (2013) 0.95
A suprapubic dermoid cyst confused with cutaneous endometriosis: a case report. Fertil Steril (2007) 0.95
A comparative study on the outcomes of in vitro fertilization between women with polycystic ovary syndrome and those with sonographic polycystic ovary-only in GnRH antagonist cycles. Arch Gynecol Obstet (2010) 0.94
[Clinical characteristics of 159 cases of acute toxic hepatitis]. Korean J Hepatol (2008) 0.94
Successful vitrification of human amnion-derived mesenchymal stem cells. Hum Reprod (2008) 0.93
Notch inhibition promotes human embryonic stem cell-derived cardiac mesoderm differentiation. Stem Cells (2008) 0.92
Cryopreservation of human embryonic stem cells without the use of a programmable freezer. Hum Reprod (2005) 0.92
Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Hum Reprod (2010) 0.92
Gastric yolk sac tumor: a case report and review of the literature. Korean J Intern Med (2009) 0.92
Effect of antifreeze protein supplementation in vitrification medium on mouse oocyte developmental competence. Fertil Steril (2011) 0.92
Methods for derivation of human embryonic stem cells. Stem Cells (2005) 0.92
Association between endometriosis and polymorphisms in endostatin and vascular endothelial growth factor and their serum levels in Korean women. Fertil Steril (2007) 0.91
Age-related distributions of anti-Müllerian hormone level and anti-Müllerian hormone models. Acta Obstet Gynecol Scand (2012) 0.90
Effects of estradiol supplementation during the luteal phase of in vitro fertilization cycles: a meta-analysis. Fertil Steril (2009) 0.90
Cryopreserved blastocyst transfer: impact of gonadotropin-releasing hormone agonist versus antagonist in the previous oocyte retrieval cycles. Fertil Steril (2007) 0.89
A case of concomitant Gilbert's syndrome and hereditary spherocytosis. Korean J Hepatol (2010) 0.89
MicroRNA expression profiles are altered by gonadotropins and vitamin C status during in vitro follicular growth. Reprod Sci (2010) 0.88
Optimal condition of vitrification method for cryopreservation of human ovarian cortical tissues. J Obstet Gynaecol Res (2011) 0.88
A rare case of a signet ring cell carcinoma of the colon mimicking a juvenile polyp. Gut Liver (2012) 0.88
Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2. Yonsei Med J (2008) 0.87
Relations between interleukin-1, its receptor antagonist gene polymorphism, and bone mineral density in postmenopausal Korean women. J Bone Miner Metab (2006) 0.87
Serum biomarkers for predicting pregnancy outcome in women undergoing IVF: human chorionic gonadotropin, progesterone, and inhibin A level at 11 days post-ET. Clin Exp Reprod Med (2012) 0.87
Increase in DNA fragmentation and apoptosis-related gene expression in frozen-thawed bovine blastocysts. Zygote (2006) 0.87
Effect of artificial shrinkage on clinical outcome in fresh blastocyst transfer cycles. Clin Exp Reprod Med (2011) 0.87
Expression of the mitochondrial ATPase6 gene and Tfam in Down syndrome. Mol Cells (2003) 0.87
Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits. Fertil Steril (2011) 0.87
The beneficial effects of antifreeze proteins in the vitrification of immature mouse oocytes. PLoS One (2012) 0.87
Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery. Fertil Steril (2008) 0.86
[Comparision between proximal gastrectomy and total gastrectomy in early gastric cancer]. Korean J Gastroenterol (2009) 0.86
Optimal vitrification protocol for mouse ovarian tissue cryopreservation: effect of cryoprotective agents and in vitro culture on vitrified-warmed ovarian tissue survival. Hum Reprod (2013) 0.86
Influence of well defined protein source on in vitro maturation of human oocyte: human follicular fluid versus human serum albumin. Fertil Steril (2007) 0.86
Clinical outcomes of endoscopic submucosal dissection for undifferentiated or submucosal invasive early gastric cancer. Clin Endosc (2011) 0.86
Vitrification of immature mouse oocyte using stepwise equilibration before or after in vitro maturation. Fertil Steril (2009) 0.85
Clinical efficacy of body mass index as predictor of in vitro fertilization and embryo transfer outcomes. J Korean Med Sci (2006) 0.85